Advertisement

N-Substituted Aromatic Compounds

  • Charles M. King
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 52)

Abstract

Aromatic compounds that have nitrogen atoms attached to their ring carbons have a potential for eliciting a variety of adverse cytotoxic, mutagenic and carcinogenic responses. The actual biological effects produced by these agents are dependent on their structure, the ability of the host organism to metabolize the compound and the response of the organism to the metabolites that are generated. Although this group of compounds is most often referred to as aromatic amines, the term N-substituted aromatic compounds is more appropriate since it is sufficiently broad to include both nitrocompounds that may be converted metabolically to aromatic amines, as well as metabolites of amines, e.g. hydroxamates, amides and nitroso derivatives, that have quite different chemical properties. This report is intended to provide insight into the carcinogenic potential of these compounds and the mechanisms by which they are believed to effect this activity.

Keywords

Polycyclic Aromatic Hydrocarbon Mammary Gland Aromatic Amine Bladder Tumor Acyl Transferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bartsch, H. and Hecker, E., 1971, On the metabolic activation of N-hydroxy-N-2-acetylaminoflourene. III. Oxidation with horseradish peroxidase to yield 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene, Biochim. Biophys. Acta., 237: 567–578.CrossRefGoogle Scholar
  2. Bartsch, H., Dworkin, M., Miller, J.A., and Miller, E.C., 1972, Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver, Biochim. Biophys. Acta., 286: 272–298.PubMedCrossRefGoogle Scholar
  3. Bartsch, H., Dworkin, C., Miller, E.C., and Miller, J.A., 1973, Formation of electrophilic N-acetoxyarylamines in cytosols from rat mammary gland and other tissues by transacetylation from the carcinogen N-hydroxy-2-acetylaminobiphenyl, Biochim. Biophys. Acta., 304: 42–55.PubMedCrossRefGoogle Scholar
  4. Bengtsson, U., Johansson, S., and Angervall, L., 1978, Malignancies of the urinary tract and their relation to analgesic abuse, Kidney Internatl., 13: 107–113.CrossRefGoogle Scholar
  5. Bhanot, 0.S., Khan, S.A., and Chambers, R.W, 1979, A new system for studying molecular mechanisms of mutation by carcinogens, J. Biol. Chem., 254: 12684–12693.Google Scholar
  6. Cardona, R.A. and King, C.M., 1976, Activation of the 0-glucuronide of the carcinogen N-hydroxy-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine–tRNA adducts, Biochem. Pharmacol., 25: 1051–1056.PubMedCrossRefGoogle Scholar
  7. Clayson, D.B., and Garner, R.C., 1976, Carcinogenic aromatic amines and related compounds, in: “Chemical Carcinogens,” C.E. Searle, ed., American Chemical Society, Washington, D.CGoogle Scholar
  8. Claxton, L. and Husingh, J., 1980, Characterization of the mutagens associated with diesel particle emissions, 11th Annual Meeting Environmental Mutagen Society, March 16–19, p. 54.Google Scholar
  9. Coogan, P.S., H.T. Maganini, J.J. Newton, Jr., and G.M. Hass, 1978, Progesterone inhibition of 2-AAF induction of urogenital tumors in rabbits, Lab. Investigations, 38: 339.Google Scholar
  10. Cramer, J.W., Miller, J.A., and Miller, E.C., 1960, N-Hydroxylation: a new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene, J. Biol. Chem., 235: 885–888.PubMedGoogle Scholar
  11. DeBaun, J.R., Miller, E.C., and Miller, J.A., 1970, N-Hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methionS-yl) binding in rat liver, Cancer Res., 30: 577–595.Google Scholar
  12. Epler, J.L., Rao, T.K., and Larimer, F.W., 1980, Isolation and identification of mutagenic polycyclic aromatic amines in synthetic crude oils. 11th Annual Meeting, Environmental Mutagen Society, March 16–19, p. 54.Google Scholar
  13. Glowinski, I.B., Weber, W.W., Fysh, J.M., Vaught, J.B., and King, C.M., 1980, Evidence that arylhydroxamic acid N,0-acyltransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rabbit liver, J. Biol. Chem., 255: 7883–7890.PubMedGoogle Scholar
  14. Glowinski, I.B., Savage, L., King, C.M., 1981, Relationship between metabolic activation and deacylation of arylhydroxamic acids by liver microsomes of several species, Proc. Am. Can Res., 22: 102.Google Scholar
  15. Gutmann, H.R., Malejka-Giganti, D., Barry, E.J., and Rydell, R.E, 1972, On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat, Cancer Res., 31: 1554–1561.Google Scholar
  16. Hoffman, D. and Wynder, E.L., 1976, Environmental respiratory carcinogenesis, in: “Chemical Carcinogens, ACS Monograph 173,” C.E. Searle, ed., American Chemical Society, Washington, D.C.Google Scholar
  17. Howard, P.C., Casciano, D.A., Beland, F.A., and Shaddock, J.G., Jr., 1981, The binding of N-hydroxy-2-acetylaminofluorene to DNA and repair of the adducts in primary rat hepatocyte cultures, Carcinogenesis., 2: 97–102.PubMedCrossRefGoogle Scholar
  18. Irving, C.C., 1966, Enzymatic deacetylation of N-hydroxy-2acetylaminofluorene by liver microsomes, Cancer Res., 26: 1390–1396.PubMedGoogle Scholar
  19. Irving, C.C., 1979, Species and tissue variations in the metabolic activation of aromatic amines, in: “Carcinogens: Identification and Mechanisms of Action,” Griffin, A.C. and Shaw, C.R., eds., Raven Press, New York.Google Scholar
  20. Irving, C.C., Janss, D.H., and Russell, L.T., 1971, Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal’s gland of the rat, Cancer Res., 31: 387–391.PubMedGoogle Scholar
  21. Irving, C..C., Wiseman, R., Jr., and Hill, J.T., 1967a, Biliary excretion of the 0–glucuronide of N–hydroxy2–acetylaminofluorene by the rat and rabbit, Can Res., 27–2309–2317.Google Scholar
  22. Jarvinen, M., Santti, R.S.S., Hopsu-Havu, V.K., 1979 Partial purification and characterization of two enzymes from guinea pig liver microsomes that hydrolyze carcinogenic amides, 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene, Biochem. Pharm., 20: 2971–2982.Google Scholar
  23. Kadlubar, F.F., Unruh, L.E., Beland, F.A., Straub, K.M., and Evans, F.A., 1980, In vitro reaction of the carcinogen, N-hydroxy-2-naphthyamine, with DNA at the C-8 and N2 atoms of guanine and at the N6atom of adenine, Carcinogenesis, 1: 139–150.PubMedCrossRefGoogle Scholar
  24. King, C.M., Allaben, W.T., 1980, Arylhydroxamic acid acyltransferase, in: “Enzymatic Basis of Detoxication, Vol. II,” W. Jakoby, ed., Academic Press, Inc.Google Scholar
  25. King, C.M., and Kriek, E., 1965, The differential reactivity of the oxidation products of o-aminophenols towards protein and nucleic acid. Biochim. Biophys. Acta., 111: 147–153.PubMedCrossRefGoogle Scholar
  26. King, C.M., and Phillips, B. 1968, Enzyme-catalyzed reactions of the carcinogen N-hydroxy-2-fluorenylacetamide with nucleic acid. Science, 159: 1351–1353.PubMedCrossRefGoogle Scholar
  27. King, C.M., and Phillips, B., 1969, N-Hydroxy-2-fluorenylacetamide. Reaction of carcinogen with guanosine, ribonucleic acid, deoxyribonucleic acid, and protein following enzymatic deacetylation or esterification, J. Biol. Chem., 244.Google Scholar
  28. King, C.M., Traub, N.R., Cardona, R.A., and Howard, R.B., 1976, Comparative adduct formation of 4-aminobiphenyl and 2-aminofluorene derivatives with macromolecules of isolated liver parenchymal cells, Can. Res., 36: 2374–2381.Google Scholar
  29. King, C.M., Traub, N.R., Lortz, Z.M.,and Thissen, M.R., 1979, Metabolic activation of arylhydroxamic acids by N-O-acyltransferase of rat mammary gland, Can Res., 3369–3372.Google Scholar
  30. Kosuge, T., Tsuji, K., Wakabayashi, K., Okamoto, T., Shudo, K., Iitaka, Y., Itai, A., Sugimura, T., Kawachi, T., Nagao, M., Yahagi, T., and Seino, Y., 1978, Isolation and structural studies of mutagenic principles in amino acid pyrolysates, Chem. Pharm. Bull., 26: 611–619.PubMedCrossRefGoogle Scholar
  31. Kriek, E., 1965 On the interaction of N-2-fluorenylhydroxylamine with nucleic acids in vitro. Biochem. Biophys. Res. Commun., 20: 793–799.Google Scholar
  32. Kriek, E., Miller, J.A., Juhl, U., and Miller, E.C., 1967, 8-(N-2-Fluorenylacetamido)guanosine, an arylamidation reaction product of guanosine and the carcinogen N-acetoxy-N-2-fluorenylacetamide in neutral solution, Biochemistry, 6: 177.Google Scholar
  33. Kriek, E., and Westra, J.G., 1979, Metabolic activation of aromatic amines and amides and interactions with nucleic acids, in: “Chemical Carcinogens and DNA, Vol. II,” Grover, P.L., ed., CRC Press, Inc., Boca Raton, FA.Google Scholar
  34. Lee, M.S., and King, C.M., 1981, New syntheses of N-(guanosin-8-yl)-4-aminobiphenyl and its 5’-monophosphate, Chem. Biol. Interactions, 34: 239–248.CrossRefGoogle Scholar
  35. Lofroth, G., 1978, Mutagenicity assay of combustion emissions, Chemosphere, 7: 791–798.CrossRefGoogle Scholar
  36. Maher, V.M., Miller, E.C., Miller, J.A., and Szybalski, W., 1968, Mutations and decreases in density of transforming DNA produced by derivatives of the carcinogens 2-acetylaminofluorene and N-methyl-4-aminoazobenzene, Mol. Pharm, 4: 411–426.Google Scholar
  37. Malejka-Giganti, D., and Gutmann, H.R., 1975, N-Hydroxy-2fluorenylacetamide, an active intermediate of the mammary carcinogen N-hydroxy-2-fluorenylbenzenesulfonamide (38980), Proc. Soc. Expl. Biol. Med., 150: 92–97.Google Scholar
  38. Mermelstein, R., Kariazides, D.K., Butler, M., McCoy, E.C., and Rosenkranz, H.S., 1981, The extraordinary mutagenicity of nitropyrenes in bacteria, Mutation Res, 89: 187–196.PubMedCrossRefGoogle Scholar
  39. Miller, E.C., 1978, Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address, Cancer Res., 38: 1479–1496.PubMedGoogle Scholar
  40. Miller, E.C., Miller, J.A.., and Hartman, H.A., 1961, N-hydroxy-2-acetylaminofluorene: A metabolite of 2-acetylaminfluorene with increased carcinogenic activity in the rat, Cancer Res., 31: 815–824.Google Scholar
  41. Moore, P., and Strauss, B.S., 1979, Sites of inhibition of in vitro DNA synthesis in carcinogen-and UV-treated clo X174 DNA, Nature, 278: 664–666.PubMedCrossRefGoogle Scholar
  42. Morton, K.C., Wang, C.Y., Garner, C.D., and Shirai, T., 1981, Carcinogenicity of benzidine, N,N’-diacetylbenzidine, and N-hydroxy-N-N’-diacetylbenzidine for female CD rats, Carcinogenesis, 2: 747–752.PubMedCrossRefGoogle Scholar
  43. National Cancer Institute, 1978a Bioassay of aniline hydrochloride for possible carcinogenicity, CAS No. 142–04–1, NIC–CG–TR–130.Google Scholar
  44. National Cancer Institute, 1978b Bioassay of o–Anisidine hydrochloride for possible carcinogenicity, CAS NO. 134–29–0, NCI–CG–TR–89.Google Scholar
  45. Neumann, H.G., 1980, On the significance of metabolic activation and binding to nucleic acids of aminostilbene derivatives in vivo, Natl. Cancer Inst. Monogr., in press.Google Scholar
  46. Parkes, H.G., 1976, “The epidemiology of the aromatic amine cancers in: Chemical carcinogens, C.E. Searle, ed., Am. Chem. Soc., Washington, D.C.Google Scholar
  47. Pitts, J.A., Jr., Van Cauwenberghe, K.S., Grosjean, D., Schmid, J.P., Fitz, D.R., Belser, W.L., Jr., Knudson, G.B., and Hynds, P.M., 1978, Atmospheric reactions of polycyclic aromatic hydrocarbons: facile formation of mutagenic nitro derivatives, Science, 202: 515–519.PubMedCrossRefGoogle Scholar
  48. Scribner, D.L., and McCloskey, J.A., 1978, Deamination of 1-methylcytosine by the carcinogen N-acetoxy-4-acetamido stilbene: Implications for hydrocarbon carcinogenesis, J. of Organic Chem, 43: 2085.CrossRefGoogle Scholar
  49. Shirai, T., Fysh, J.M., Lee, M.S., Vaught, J.B.,and King, C.M., 1981a, N-hydroxy-N-acylarylamines: relationship of metabolic activation to biological response in the liver and mammary gland of the female CD rat, Cancer Res: 41: 4346–4353.Google Scholar
  50. Shirai, T., and King, C.M., 1981b, Relationship of H-thymidine incorporation to the metabolic activation of arylhydroxamic acids by rat hepatocytes, Proc. Am Assoc. Can Res: 22: 99.Google Scholar
  51. Shirai, T., Lee, M.S., Wang, C.Y., King, C.M., 1981c, Effects of partial hepatectomy and dietary phenobarbital on liver and mammary tumorigenesis by two N-hydroxy-N-acylaminobiphenyls in female CD rats, Cancer Res., 41: 2350–2456.Google Scholar
  52. Thorgeirsson, S.S., Wirth, P.J., Nelson, W.L., and Lambert, G.H., 1977, Genetic regulation of metabolism and mutagenicity of 2-acetylaminofluorene and related compounds in mice, in: “Origins of Human Cancer,”Hiatt, Watson, Winsten, eds., Cold Spring Harbor, NY.Google Scholar
  53. Vaught, J.B., Lee, M.S., Shayman, M.A., Thissen, M.R., and King, C.M, 1981, Arylhydroxylamine-induced ribonucleic acid chain cleavage and chromatographic analysis of arylamine ribonucleic acid adducts, Chem. Biol Interactions, 34: 109–124.CrossRefGoogle Scholar
  54. Wang, C.Y., Lee, M.S., King, C.M., and Warner, P.O., 1980, Evidence for nitroaromatics as direct-acting mutagens as airborne particulates, Chemosphere, 9: 83–87.CrossRefGoogle Scholar
  55. Weber, W.W., 1973, Acetylation of drugs, in: “Metabolic conjugation and metabolic hydrolysis”, W.H. Fishman, ed., Academic Press, New York.Google Scholar
  56. Weeks, C.E., Allaben, W.T., Louie, S.C., Lazear, E.J., and King, C.M., 1978, Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2fluorenylacetamide in Salmonella typhimurium, Cancer Res., 38: 613–618.PubMedGoogle Scholar
  57. Weeks, C.E., Allaben, W.T., Tresp, N.M., Louis, S.C., Lazear, E.J., and King, C.M., 1980, Effects of structure of N-acyl-N-2-fluorenylhyroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase and deacylase activities, and on mutations in Salmonella Typhimurium TA 1538, Cancer Res., 40: 1204–1211.PubMedGoogle Scholar
  58. Wirth, P.J., and Thorgeirsson, S.S., 1980, Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system, role of N-O-acyltransferase and sulfotransferase from rat liver, Mol. Pharm: 19: 337–344.Google Scholar
  59. Wu, S-C.G., and Straub, K.D., 1976,. Purification and characterization of N-hydroxy-2-acetylaminofluorene sulfotransferase from rat liver, J. Biol. Chem., 251: 6529–6536.Google Scholar
  60. Zavon, M.R., Hoegg, R., and Bingham, E., 1973, Benzidine exposure as a cause of bladder tumors, Arch. Environ. Health, 27: 1–7.PubMedGoogle Scholar
  61. Zenser, T.V., Mattammal, M.B., Armbrecht, H.J., and Davis, B.B., 1980, Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase, Can Res., 40: 2839–2845.Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Charles M. King
    • 1
  1. 1.Department of Chemical CarcinogenesisMichigan Cancer FoundationDetroitUSA

Personalised recommendations